SEARCH

SEARCH BY CITATION

References

  • 1
    Ockene I, Shay M, Alpert J, et al. Unexplained chest pain in patients with normal coronary arteriograms. N Engl J Med. 1980;303:12491252.
  • 2
    Lerman A, Burnett J, Higano S, et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation. 1998;97:21232128.
  • 3
    Iriarte M, Caso R, Murga N, et al. Microvascular angina in systemic hypertension: diagnostic and treatment with enalapril. Am J Cardiol. 1995;76:31D34D.
  • 4
    Hasdai D, Cannan C, Mathew V, et al. Evaluation of patients with minimally obstructive coronary artery disease and angina. Int J Cardiol. 1996;53:203208.
  • 5
    Prisant LM, von Dohlen TW, Houghton JL, et al. A negative thallium (+/− dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients. Am J Hypertens. 1992;5:7175.
  • 6
    Houghton J, Prisant L, Carr A, et al. Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease. Am Heart J. 1991;121:11071112.
  • 7
    Houghton JL, Carr AA, Prisant LM, et al. Morphologic, hemodynamic, and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia. Am J Cardiol. 1992;69:219224.
  • 8
    Houghton J, Saxena R, Frank M. Angina and ischemic electrocardiographic changes secondary to coronary arteriovenous fistula with abnormal basal and reserve coronary blood flow. Am Heart J. 1993;125:886889.
  • 9
    Houghton J, Prisant L, Carr A, et al. Racial differences in myocardial ischemia and coronary flow reserve in hypertension. J Am Coll Cardiol. 1994;23:11231129.
  • 10
    Troy B, Pombo J, Rackley C. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972;45:602611.
  • 11
    Levy D, Savage D, Garrison R, et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;59:956960.
  • 12
    Leppo J, Boucher C, Okada R, et al. Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenosis and relationships to regional wall motion. Circulation. 1982;66:649657.
  • 13
    Watson D, Campbell N, Read E, et al. Spatial and temporal quantification of plane thallium myocardial images. J Nucl Med. 1981;22:577584.
  • 14
    Sibley DH, Millar HD, Hartley CJ, et al. Subselective measurement of coronary blood flow velocity using a steerable Doppler catheter. J Am Coll Cardiol. 1986;8:13321340.
  • 15
    Houghton JL, Frank MJ, Carr AA, et al. Relations among impaired coronary flow reserve, left ventricular hypertrophy, and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol. 1990;15:4351.
  • 16
    Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Med Care. 1992;30:473483.
  • 17
    Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (The Duke Activity Scale Index). Am J Cardiol. 1989;64:651654.
  • 18
    Ware JJ, Kosinski M, Bayliss M, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures. Med Care. 1995;33(suppl): AS264AS279.
  • 19
    Ware J, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston , MA : The Health Institute, New England Medical Center; 1993.
  • 20
    Ware J, Kosinski M, Keller S. Physical and Mental Health Summary Scales: A User's Manual. Boston , MA : Health Assessment Lab; 1994.
  • 21
    Shen W, Cai X, Zhang D, et al. Abnormal coronary flow reserve in patients with angina pectoris and hypertensive left ventricular hypertrophy. Chinese Med J. 1996;109:376380.
  • 22
    Mensah G. Left ventricular hypertrophy at the limits. In: OpieL, YellonD, eds. Cardiology at the Limits. 2nd ed. Ndabeni , South Africa : Rustica Press; 1998:99123.
  • 23
    Liao Y, Cooper R, McGee D, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 1995;273:15921597.
  • 24
    Hamaski S, Suwaidi J, Higano S, et al. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol. 2000;35:16541660.
  • 25
    Epstein S, Cannon R, Bonow R. Exercise testing in patients with microvascular angina. Circulation. 1991;83:III73III76.
  • 26
    Fragasso G, Rossetti E, Dosio F, et al. High prevalence of the thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur Heart J. 1996;17:14821487.
  • 27
    Vassalli G, Hess O. Measurement of coronary flow reserve and its role in patient care. Basic Res Cardiol. 1998;93:339353.
  • 28
    Baumgart D, Haude M, Liu F, et al. Current concepts of coronary flow reserve for clinical decision making during cardiac catheterization. Am Heart J. 1998;136:136149.
  • 29
    Serruys P, di Mario C, Piek J, et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: The DEBATE study. Circulation. 1997;96:33693377.
  • 30
    Kern MJ, Donohue TJ, Aguirre FV, et al. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol. 1995;25:178187.
  • 31
    Lesser J, Wilson F, White C. Physiologic assessment of coronary stenoses of intermediate severity can facilitate patient selection for coronary angioplasty. Coron Art Dis. 1990;1:697705.
  • 32
    Kaski J, Rosano G, Collins P, et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol. 1995;25:807814.
  • 33
    Haley J, Miller T, Christian T, et al. Twelve-year outcome of patients with an abnormal exercise radionuclide left ventricular angiogram and angiographically insignificant coronary artery disease. Am J Cardiol. 1998;82:418422.
  • 34
    Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:10271035.
  • 35
    Sowers J, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension. 1995;26:869879.
  • 36
    Haffner S, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229234.
  • 37
    Atienza F, Velasco JA, Brown S, et al. Assessment of quality of life in patients with chest pain and normal coronary arteriogram (syndrome X) using a specific questionnaire. Clin Cardiol. 1999;22:283290.